$DFTX

$37.96▲ -0.4% YTD

6 SEC 13D/G filings tracked · Last updated Oct 29, 2026

Filing History

News

DFTX ▼ -0.4% - Definium Therapeutics, Inc.

CP $37.96▲ -0.4%Oct 29, 2026 · ThinkSabio Blog

$DFTX - Definium Therapeutics to Report Third Quarter 2026 Financial Results on November 9, 2026…

News

DFTX ▲ +4.2% - Definium Therapeutics, Inc.

CP $35.61▲ +4.2%Oct 9, 2026 · ThinkSabio Blog

$DFTX JPMorgan initiated coverage of Definium Therapeutics with an Overweight rating and $84 price target. The company's lead asset DT120 ODT is being…

News

DFTX ▲ +6.6% - Definium Therapeutics, Inc.

CP $41.46▲ +6.6%Sep 14, 2026 · ThinkSabio Blog

$DFTX Definium Therapeutics Announces Positive Topline Results from Phase 3 Panorama Study of DT120 ODT in Generalized Anxiety Disorder…

News

DFTX ▲ +1.2% - Definium Therapeutics, Inc.

CP $38.55▲ +1.2%Sep 8, 2026 · ThinkSabio Blog

$DFTX Definium Therapeutics Receives Breakthrough Therapy Designation for DT120 (lysergide) Orally Disintegrating Tablet (ODT) in Major Depressive Dis…

SEC 13D/G

DFTX - Definium Therapeutics, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks Simplified

$42.80▲ 213.55%Aug 14, 2026 · ThinkSabio Blog

$DFTX SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #DFTX Definium Therapeutics, Inc. : $42.80 Sector: Healthcare |…

SEC 13D/G

DFTX - Definium Therapeutics, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks Simplified

$44.18▲ 223.66%Aug 14, 2026 · ThinkSabio Blog

$DFTX SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #DFTX Definium Therapeutics, Inc. : $44.18 Sector: Healthcare |…